510(k) · Cleared
ClearedAblamap Software
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ablacon, Inc. · DQK Computer, Diagnostic, Programmable
Cleared on Aug 31, 2021 as substantially equivalent to K171583 (Abbott Electrophysiology, 2017) after a 322-day review. Its family tree reaches back 8 generations to 2000. 2 later devices descend from it.
- Decided
- Aug 31, 2021
- Review
- 322 days
- Class
- Class II
- Product code
- DQK
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 8 generations to K000248 (2000). 15 ancestors in all, the oldest K983171 (1999). 2 later devices descend from it, 1 citing it directly.
- Root · 8 generations backK000248 Carto EP Navigation SystemBiosense Webster, Inc. · 2000
- 7 generations backK013083 Carto XP EP Navigation SystemBiosense Webster, Inc. · 2001
- 6 generations backK110878 Rhythmview (TM)Topera, Inc. · 2011
- 5 generations backK123295 Rhythm ViewTopera, Inc. · 2013
- 4 generations backK142901 RhythmView WorkstationTopera, Inc. · 2014
- 3 generations backK151245 Rhythm View Workstation (non-streaming, steaming option)Topera, Inc. · 2015
- 2 generations backK161240 Rhythm View Workstation (non-streaming)Abbott Electrophysiology · 2016
- 1 generation backK171583 RhythmView WorkstationAbbott Electrophysiology · 2017
- This deviceK203084 Ablamap SoftwareAblacon, Inc. · 2021
- Descendant · cites it directly · 1 of its ownK230008 Ablamap® SystemAblacon, Inc. · 2023
- Descendant · 2 generations on · 0 of its ownK251344 OptiMap™ SystemBoston Scientific Corporation · 2025
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −8 | K000248 | Carto EP Navigation System | Biosense Webster, Inc. | 2000 | — |
| −7 | K013083 | Carto XP EP Navigation System | Biosense Webster, Inc. | 2001 | — |
| −6 | K110878 | Rhythmview (TM) | Topera, Inc. | 2011 | — |
| −5 | K123295 | Rhythm View | Topera, Inc. | 2013 | — |
| −4 | K142901 | RhythmView Workstation | Topera, Inc. | 2014 | — |
| −3 | K151245 | Rhythm View Workstation (non-streaming, steaming option) | Topera, Inc. | 2015 | — |
| −2 | K161240 | Rhythm View Workstation (non-streaming) | Abbott Electrophysiology | 2016 | — |
| −1 | K171583 | RhythmView Workstation | Abbott Electrophysiology | 2017 | — |
| 0 (this device) | K203084 | Ablamap Software | Ablacon, Inc. | 2021 | — |
| +1 | K230008 | Ablamap® System | Ablacon, Inc. | 2023 | — |
| +2 | K251344 | OptiMap™ System | Boston Scientific Corporation | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2013 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DQK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DQK device
- #1 K213682 HemoSphere Advanced Monitor, HemoSphere…score 26.6 · 28 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K171583 | RhythmView WorkstationSummary page 4…trophysiology 510(k) Submitter/Holder: 3668 S. Geyser Road Ste 365 St. Louis, MO 63127 510(k) #s: K171583 510(k): Ablacon Ablamap® Software 510(k) Summary - K203084 1 Device Description The Ablacon Ablam… | 2017 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K230008 | Ablamap® System | 2023 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 1.6 years on median.
- 6 of the 15 ancestors have a recall of any class.
- Of its descendants, K230008 (Ablacon, Inc., 2023) has gone furthest, with 1 descendant of its own.
How does its category compare?
All DQK devicesDQK Computer, Diagnostic, Programmable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · DQK
23so far in 2026, the most since 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · DQK
95in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DQK
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DQK
433in 2025
MAUDE reports naming product code DQK, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 13 | 83 | 4 | 18 |
| 2008 | 4 | 70 | 1 | 34 |
| 2009 | 12 | 93 | 2 | 40 |
| 2010 | 9 | 64 | 3 | 49 |
| 2011 | 12 | 69 | 2 | 55 |
| 2012 | 7 | 74 | 3 | 129 |
| 2013 | 13 | 68 | 1 | 180 |
| 2014 | 9 | 90 | 4 | 115 |
| 2015 | 7 | 125 | 2 | 131 |
| 2016 | 15 | 190 | 0 | 340 |
| 2017 | 7 | 146 | 2 | 252 |
| 2018 | 14 | 150 | 6 | 261 |
| 2019 | 15 | 113 | 1 | 218 |
| 2020 | 16 | 123 | 1 | 215 |
| 2021 | 16 | 132 | 1 | 351 |
| 2022 | 19 | 136 | 2 | 319 |
| 2023 | 21 | 133 | 2 | 340 |
| 2024 | 13 | 100 | 24 | 557 |
| 2025 | 22 | 95 | 1 | 433 |
| 2026 | 23 | 151 | 2 | — |
What is it indicated for?
The Ablamap® Software is used to analyze electrogram (EGM) signals and display results in a visual format for
evaluation by a physician in order to assist in the diagnosis of complex cardiac arrhythmias.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K203084 · printed Nov 6, 2026
Cite this page
510(k) Report. “K203084: Ablamap Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203084
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026